Mutual of America Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Mutual of America Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-46,928	Closed	-$2.96M	–	1681
2020 Q2	$2.96M	Sell	46,928 -3,176	-6%	-$218K	0.04%	619
2020 Q1	$2.56M	Sell	50,104 -2,202	-4%	-$147K	0.04%	582
2019 Q4	$4.16M	Buy	52,306 +18,353	+54%	+$1.09M	0.05%	542
2019 Q3	$1.65M	Sell	33,953 -189	-0.6%	-$9.85K	0.02%	938
2019 Q2	$1.8M	Buy	34,142 +5,642	+20%	+$324K	0.03%	927
2019 Q1	$1.51M	Buy	+28,500	New	+$1.4M	0.02%	989

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mutual of America Capital Management's GBT Position: Q3 2020 in Review

Mutual of America Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 46,928 shares — an estimated $2.96M sold.

Mutual of America Capital Management first reported a position in GBT in Q1 2019 and held it in 6 quarters. The position peaked at $4.16M in Q4 2019. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

Mutual of America Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
Mutual of America Capital Management sold 46,928 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $2.96M.
Mutual of America Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and held it in 6 quarters.
Mutual of America Capital Management's Global Blood Therapeutics, Inc. position peaked at $4.16M in Q4 2019.
229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Mutual of America Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.